Pneumococcal conjugate second or third-dose vaccines (PCVc) in Ethiopia

Ethiopia: Pneumococcal conjugate second or third-dose vaccines (PCVc) was 81.0% in 2025. ◆ Volatile

Latest (2025)
81.0%
Change on year
up 8.0%
World rank
113th
of 194 countries
All-time high
81.0%
in 2025
All-time low
0.0%
in 2008
Years of data
18
2008–2025

Pneumococcal conjugate second or third-dose vaccines (PCVc) in Ethiopia, 2008–2025

0204060802008201620252008: 02009: 02010: 02011: 122012: 302013: 482014: 552015: 582016: 612017: 642018: 672019: 692020: 712021: 692022: 712023: 752024: 752025: 81

Source: World Health Organization, Global Health Observatory.

Analysis

The most recent figure for pneumococcal conjugate second or third-dose vaccines (pcvc) in Ethiopia is 81.0%, measured in 2025. That is the highest value across all 18 years on record.

Compared with earlier readings it is up 8.0% on the previous year and up 39.7% over ten years.

Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) in Ethiopia peaked at 81.0% in 2025 and was at its lowest, 0.0%, in 2008.

That places Ethiopia 113th out of 194 countries with data for 2025, putting it in the middle of the range.

The series is highly variable year to year, so single readings are best treated with caution.

Pneumococcal conjugate second or third-dose vaccines (PCVc) in Ethiopia, year by year

Annual values for Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC) in Ethiopia, 2008 to 2025.
Year Value Change
2008 0.0% —
2009 0.0% —
2010 0.0% —
2011 12.0% —
2012 30.0% +150.0%
2013 48.0% +60.0%
2014 55.0% +14.6%
2015 58.0% +5.5%
2016 61.0% +5.2%
2017 64.0% +4.9%
2018 67.0% +4.7%
2019 69.0% +3.0%
2020 71.0% +2.9%
2021 69.0% -2.8%
2022 71.0% +2.9%
2023 75.0% +5.6%
2024 75.0% +0.0%
2025 81.0% +8.0%

Ethiopia compared with similar countries

  • Ethiopia's 81.0% is above the median for low income countries, which is 80.0%, 1.0× the median. (25 countries reporting)
  • Ethiopia's 81.0% is below the median for Sub-Saharan Africa, which is 82.5%, 98% of the median. (48 countries reporting)

Biggest year-on-year movements

Years where Pneumococcal conjugate second or third-dose vaccines (PCVc) in Ethiopia changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.

YearChange FromTo
2012 +150.0% 12.0% 30.0%
2013 +60.0% 30.0% 48.0%

Averages by decade

DecadeAverage LowestHighest Years
2000s 0.0% 0.0% 0.0% 2
2010s 46.4% 0.0% 69.0% 10
2020s 73.7% 69.0% 81.0% 6

Countries ranked near Ethiopia

  1. 113 Ireland 81.0% compare
  2. 113 San Marino 81.0% compare
  3. 113 Albania 81.0% compare
  4. 113 Mali 81.0% compare

See the full ranking of 207 places →

More health data for Ethiopia

All data for Ethiopia →

Frequently asked questions

What is pneumococcal conjugate second or third-dose vaccines (pcvc) in Ethiopia?
Pneumococcal conjugate second or third-dose vaccines (pcvc) in Ethiopia was 81.0% in 2025, according to World Health Organization, Global Health Observatory.
What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Ethiopia?
The highest recorded value was 81.0% in 2025.
What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Ethiopia?
The lowest recorded value was 0.0% in 2008.
How does Ethiopia rank for pneumococcal conjugate second or third-dose vaccines (pcvc)?
Ethiopia ranks 113th out of 194 countries with data for 2025.
Is pneumococcal conjugate second or third-dose vaccines (pcvc) rising or falling in Ethiopia?
Over the last ten years it is up 39.7%. The long-run trend across the full record is volatile.
Where does this Ethiopia data come from?
The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).

Share, cite or embed this page

Cite this page

Pneumococcal conjugate second or third-dose vaccines (PCVc) in Ethiopia. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 26 September 2026, from https://health.statizoid.com/stat/pneumococcal-conjugate-second-or-third-dose-vaccines-pcvc-immunization-coverage-by-the/ethiopia/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/stat/pneumococcal-conjugate-second-or-third-dose-vaccines-pcvc-immunization-coverage-by-the/ethiopia/">Pneumococcal conjugate second or third-dose vaccines (PCVc) in Ethiopia</a> — Statizoid

About this data

Indicator
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
207 places, 3,723 data points, 2008–2025
Last refreshed